Vera Therapeutics, Inc. (VERA)
42.30
+0.06
(+0.14%)
USD |
NASDAQ |
Apr 17, 16:00
42.48
+0.18
(+0.43%)
Pre-Market: 08:28
Vera Therapeutics SG&A Expense (Quarterly) : 34.90M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 23.93M |
| Syndax Pharmaceuticals, Inc. | 49.93M |
| United Therapeutics Corp. | 160.80M |
| Cytokinetics, Inc. | 91.72M |
| Insmed, Inc. | 212.48M |